Pharmabiz2d
Enanta Pharma announces top-line results for EDP-323 in phase 2a human challenge study of healthy adults infected with RSV
Watertown, Massachusetts Saturday, September 28, 2024, 18:00 Hrs [IST] ...
Enanta Pharmaceuticals (ENTA) Gets a Hold from Leerink Partners
Leerink Partners analyst Roanna Ruiz maintained a Hold rating on Enanta Pharmaceuticals (ENTA – Research Report) yesterday. The ...
J&J builds case for Talvey; FDA panel questions PD-1 drugs for certain cancers
New data show Talvey’s potential in multiple myeloma drug combinations. Elsewhere, AbbVie got more positive Parkinson’s drug ...
The Pharma Letter3d
Enanta’s next RSV pill raises ‘high bar set by zelicapavir’
Enanta Pharmaceuticals announced positive topline results from a Phase IIa trial of EDP-323, its RSV replication inhibitor, ...
Enanta Pharmaceuticals Gains Buy Rating on Strong Clinical Results for EDP-323
In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on Enanta Pharmaceuticals (ENTA – Research Report), ...
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...
Business Wire4d
Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With RSV ...
FierceBiotech4d
Enanta's RSV antiviral crushes viral load in challenge study
Enanta Pharmaceuticals has linked its respiratory syncytial virus (RSV) antiviral to significant reductions in viral load and ...
Pharmaceutical Technology6d
Enanta Pharmaceuticals gets grant for compounds for treating hepatitis b virus infections
Discover Enanta Pharmaceuticals' groundbreaking patent for HBV-inhibiting compounds, offering new hope for effective hepatitis B treatments and improved patient outcomes.